Quality Culture and The Role of Management

quality cultureIn the pharmaceutical and medical device industries, quality culture plays an essential role in profit generation, product safety and approval from regulatory bodies. As a result, organizations must prioritize maintaining product and process quality. One significant aspect of quality control is data integrity — a company’s data should be complete, consistent and accurate in both paper and electronic forms.

 

The adoption of electronic record keeping systems has led to a resurgence in data integrity citations. In response, many regulatory agencies — including the Food and Drug Administration (FDA), the Medicines and Healthcare Products Regulatory Agency (MHRA), the Pharmaceutical Inspectorate Consortium (PICS) and the World Health Organization (WHO) — have released guidance on data integrity. Many of these reports discuss quality culture as a key part of maintaining data integrity in life sciences.

 

What Is a Quality Culture?

 

Within an organization, quality culture is a working environment in which the risk of noncompliant and erroneous data and records is minimized. Creating a quality culture requires that all members of an organization encourage the open reporting of errors, omissions and other threats to data integrity and product quality.

 

As the WHO and other regulatory agencies have noted, management must be involved with the creation of a quality culture. Quality control should not be limited to the quality management team, but rather flow across all levels of leadership. Managers and other business leaders must be just as accountable for data integrity as everyone else.

 

How Can Management Contribute?

 

As awareness about the importance of quality increases, pharmaceutical companies are likely to see more requests for documentation demonstrating a commitment to quality and data integrity. Quality is also likely to impact a company’s finances — organizations with highly developed quality cultures may spend around $350 million less fixing mistakes every year.

 

To remain competitive, every business must consider the role of management in quality culture. Here are four ways leaders can contribute to quality in pharmaceutical, medical device, biologics and other organizations:

 

  • Lead by example: Quality culture must be encouraged from the top down. If managers and leaders demonstrate a commitment to quality, people throughout the company will follow.
  • Update reporting procedures: Managers should review and update their companies’ reporting procedures to elevate and address issues with data systems when they arise.
  • Review your audit schedule: While regulators don’t require internal audits, they are an important part of upholding data integrity. Review your audit schedule and ensure you are also auditing contract manufacturers and other outside parties.
  • Act on audit results: When an audit reveals gaps in data integrity, act immediately to address the problem. This shows you take quality seriously. You can address issues independently or seek help from experts like those at Regulatory Compliance Associates.

 

Learn More About Data Integrity and Quality Culture

 

The management role in quality culture is a hot topic in the life sciences industry. To learn more about data integrity and quality, contact Regulatory Compliance Associates or listen to the RCA Radio podcast. In the latest episode, host and RCA’s own, Erika Porcelli and Susan Schniepp discuss the history of data integrity and how management can integrate quality into the product lifecycle.

 

Additional Blog Updates

 

Frequently Asked Questions on Deviations

Preparing for an FDA Virtual Audit — The Best Practices

How to Avoid Supply Chain Interruptions

News

Vice News Interview: Coronavirus Is Revealing Gaping Holes in America’s Drug Supply Chain...
Read More

News

Vice News Interview: Coronavirus Is Revealing Gaping Holes in America’s Drug Supply Chain...
Read More

News

Vice News Interview: Coronavirus Is Revealing Gaping Holes in America’s Drug Supply Chain...
Read More
Regulatory Compliance Associates® Inc. Welcomes Steven Lynn as Executive Vice President of Pharmaceuticals...
Read More
2018 Compounding Policy Priorities Plan...
Read More

Our website uses cookies to give you the best possible experience.

By continuing to use this site, you agree to the use of cookies.
Continue